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There is recent evidence that IL-17–secreting 
CD4+ T cells (Th17 cells) play a key role in 
autoimmune diseases, such as rheumatoid arthritis 
(RA) and multiple sclerosis (Harrington et al., 
2005; Veldhoen et al., 2006; Korn et al., 2009). 
It remains unclear, however, how pathogenic 
self-reactive Th17 cells are generated from naive 
T cells, and are activated by external or internal 
stimuli in autoimmune disease.
SKG mice, a mutant of the gene encoding 
ZAP-70 on the BALB/c background, sponta-
neously develop CD4+ T cell–mediated autoim-
mune arthritis clinically and immunologically 
resembling human RA (Sakaguchi et al., 2003). 
The mutation alters the sensitivity of develop-
ing T cells to positive and negative selection in 
the thymus, leading to thymic production of 
potentially arthritogenic autoimmune T cells 
(Sakaguchi et al., 2003; Hirota et al., 2007). 
The SKG arthritis is critically dependent on 
Th17 cells, as deficiency of either IL-17 or IL-6 
completely inhibits the disease (Hirota et al., 
2007). Importantly, they spontaneously develop   
severe arthritis in a microbially conventional 
environment but not under a specific pathogen–
free (SPF) condition, suggesting that environ-
mental stimuli such as microbial infection may 
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Activation of serum complement triggers Th17 cell–dependent spontaneous autoimmune 
disease in an animal model. In genetically autoimmune-prone SKG mice, administration  
of mannan or -glucan, both of which activate serum complement, evoked Th17 cell–
  mediated chronic autoimmune arthritis. C5a, a chief component of complement activation pro-
duced via all three complement pathways (i.e., lectin, classical, and alternative), stimulated 
tissue-resident macrophages, but not dendritic cells, to produce inflammatory cytokines 
including IL-6, in synergy with Toll-like receptor signaling or, notably, granulocyte/macro-
phage colony-stimulating factor (GM-CSF). GM-CSF secreted by activated T cells indeed 
enhanced in vitro IL-6 production by C5a-stimulated macrophages. In vivo, C5a receptor  
(C5aR) deficiency in SKG mice inhibited the differentiation/expansion of Th17 cells  
after mannan or -glucan treatment, and consequently suppressed the development of 
arthritis. Transfer of SKG T cells induced Th17 cell differentiation/expansion and produced  
arthritis in C5aR-sufficient recombination activating gene (RAG)/ mice but not in C5aR-
deficient RAG/ recipients. In vivo macrophage depletion also inhibited disease development 
in SKG mice. Collectively, the data suggest that complement activation by exogenous or 
endogenous stimulation can initiate Th17 cell differentiation and expansion in certain auto-
immune diseases and presumably in microbial infections. Blockade of C5aR may thus be 
beneficial for controlling Th17-mediated inflammation and autoimmune disease.
©  2010  Hashimoto  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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mice, we prepared SKG mice deficient in C5aR (CD88; 
Hawlisch et al., 2005). The incidence and severity of arthri-
tis was significantly suppressed in mannan-treated C5aR/ 
SKG mice (Fig. 2 A). The measurement of serum C3a and 
C5a revealed that the treatment strongly triggered comple-
ment activation for the first 3 d, with persisting low level 
activation over 28 d in mannan-elicited arthritic SKG mice   
(Fig. S1). Mannan-treated C5aR+/+ SKG mice, when exam-
ined 8 wk (Fig. 2, B–E) or 2 wk (Fig. S1) after treatment, 
showed a marked hypertrophy of the regional lymph nodes 
(Fig. 2 B), which contained a much higher ratio and abso-
lute number of IL-17+ CD4+ T cells compared with similarly 
expand or trigger the differentiation of arthritogenic Th17 cells   
(Yoshitomi et al., 2005). Indeed, injection of zymosan, a 
crude extract of yeast cell wall containing -glucans or purified 
-glucans, such as laminarin, activates innate immunity via 
Toll-like receptor (TLR) and Dectin-1, and drives preferential 
differentiation and expansion of Th17 cells, thereby trigger-
ing arthritis in SKG mice under a SPF condition (Yoshitomi 
et al., 2005; LeibundGut-Landmann et al., 2007). Because 
zymosan is also an activator of the alternative pathway of 
complement (Mullaly and Kubes, 2007) and -glucan structure 
can be recognized by ficolin-L, an initiator of the lectin 
pathway (Garlatti et al., 2007), it is also likely that comple-
ment activation may contribute to triggering Th17-mediated 
autoimmune disease.
In this report, we show that complement activation via all 
three pathways (i.e., the lectin, classical, and alternative path-
ways) and the resulting generation of the common product 
C5a potently promote the differentiation/expansion of self-
reactive T cells to Th17 cells that mediate autoimmune arthritis 
in SKG mice. The results indicate that exogenous or endog-
enous stimuli that activate complement can be a triggering 
cause of Th17-mediated autoimmune disease and that C5a is 
a key molecular target in controlling Th17-mediated autoim-
munity as well as microbial immunity.
RESULTS AND DISCUSSION
Mannan triggers autoimmune arthritis by expanding  
Th17 cells
We first tested whether mannan, a prototypic activator of the 
lectin pathway of complement activation, was able to trigger 
arthritis in SKG mice (Fig. 1, A–E; Fujita, 2002). A single i.p. 
injection of 20 mg mannan triggered self-sustained chronic 
arthritis within 2 wk in all of the treated SKG mice but 
not in BALB/c mice. A small amount (200 µg) also elicited 
joint swelling, but only in a few small joints and in 50% of SKG 
mice. IL-17/ SKG mice were completely resistant to arthritis 
induction by mannan (Fig. 1 F). The ratio of IL-17+ cells 
among CD4+ T cells was increased significantly (approximately 
fourfold) in regional (e.g., popliteal) lymph nodes of mannan-
treated SKG mice with arthritis (e.g., in ankles) compared with 
control PBS-treated SKG mice without arthritis; the ratio also 
increased significantly, although to a much lesser degree, in 
mannan-treated BALB/c mice (Fig. 1, G and H). Thus, mannan 
can enhance the development of arthritogenic Th17 cells and 
evoke arthritis in SKG mice.
C5aR is essential for driving Th17 cell differentiation  
and triggering arthritis
C5a, a key common product of all three complement activation 
pathways, is the most potent complement-derived mediator 
of inflammation; increases the production of IL-6, TNF, and 
IL-1 from TLR-stimulated macrophages; and suppresses IL-12 
production  (Guo  and  Ward,  2005;  Hawlisch  et  al.,  2005; 
Zhang et al., 2007). To examine possible effects of mannan 
treatment on C5a production via the lectin pathway, and 
consequently Th17 cell differentiation and expansion in SKG 
Figure 1.  Mannan triggers autoimmune arthritis by expanding 
Th17 cells. (A) Joint score of 812-wk-old SKG or BALB/c mice that 
received a single i.p. injection of mannan at the indicated doses. A total of 
two independent experiments are shown. Error bars are means ± SD of 
scores. (B–E) A representative joint swelling and histology of an SKG  
(B and D) and a BALB/c mouse (C and E) 8 wk after mannan treatment 
(hematoxylin and eosin staining). Bars, 200 µm. (F) Joint scores of IL-17+/+ 
or IL-17/ SKG mice 8 wk after mannan treatment (n = 12). Horizontal 
bars are the means of each group. (G) Intracellular staining of IL-17 and 
IFN- in CD4+ T cells in the popliteal lymph nodes from SKG or BALB/c mice 
8 wk after mannan treatment (numbers indicate percentages). One repre-
sentative staining out of six independent experiments is shown. (H) Per-
centages of IL-17+ cells in CD4+ T cells in each SKG or BALB/c group (n = 6), 
as shown in G. Horizontal bars are the means of each group.JEM VOL. 207, June 7, 2010  1137
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in particular can commonly activate complement to   
produce C5a, which critically contributes to evoking   
autoimmune arthritis in SKG mice.
Although  the  lectin  and  alternative  pathways  are 
stimulated by microbial products such as mannan or 
zymosan, the classical pathway can be activated by anti-
gen–antibody immune complexes (ICs; Guo and Ward, 
2005). ICs not only activate complement but also deliver 
signal through FcR on APCs (Sylvestre et al., 1996). As 
such, we asked whether an IgG3-IC, which is known to 
activate the classical and alternative complement path-
ways without the involvement of FcR, would expand 
Th17 cells in a C5a/C5aR-dependent manner (Fig. 2 I; 
Díaz de Ståhl et al., 2003). C5aR+/+ and C5aR/ SKG 
mice were i.p. injected with trinitrophenyl (TNP) hapten–
conjugated BSA alone or with ICs formed of TNP-BSA 
and a TNP-specific IgG3 mAb. Compared with the in-
jection of BSA-TNP alone, IL-17+ cells were markedly 
increased in the peritoneal cavity of C5aR+/+ SKG but 
not C5aR/ SKG mice after i.p. injection of the ICs, 
although this single-dose injection failed to elicit arthritis 
in the former. Collectively, activation of all three com-
plement activation pathways facilitates Th17 cell differentia-
tion and expansion via C5a/C5aR.
C5a acts on tissue-resident macrophages to drive  
Th17 cell differentiation
C5aR was highly expressed on neutrophils (as CD11b-
highGr-1highF4/80  cells)  and  monocytes/macrophages  (as 
CD11bhighF4/80+Gr-1low/ cells) in the peritoneal cavity or 
the spleen of nontreated SKG mice (Fig. 3 A), and in arthritic   
joints of mannan-treated SKG mice (Fig. 3 B). To determine 
the cell types that received C5aR signaling and drove Th17 
cell differentiation, we cultured naive BALB/c CD4+ T cells 
with various types of APCs and stimulated them with anti-CD3 
in the presence or absence of C5a and/or TGF-. Notably, 
treated C5aR/ SKG mice (Fig. 2, C–E) or BALB/c mice 
(not depicted).
Similar to mannan treatment, arthritis elicitation by lam-
inarin or zymosan was significantly suppressed in C5aR/ 
SKG mice (Fig. 2 F). The C3 deposition assay, in which the 
amount of activated C3c was quantified by ELISA, showed 
that laminarin and zymosan activated complement (Fig. 2 G). 
The C3c deposition was reduced by the use of mannose-
binding lectin-associated serine protease (MASP)–null serum, 
indicating the involvement of the lectin pathway (Fujita, 
2002; Iwaki et al., 2006; Takahashi et al., 2008). C5a was 
indeed detected in the supernatant sera of the C3 deposition 
assay after complement activation (Fig. 2 H). These results 
collectively indicate that laminarin, zymosan, and mannan   
Figure 2.  C5a drives Th17 cell differentiation and triggers 
arthritis. (A) Joint score of C5aR+/+ or C5aR/ SKG mice treated by 
20 mg mannan. A total of two independent experiments are shown. 
Error bars are means ± SD of scores. *, P < 0.05. (B) Spleen and pop-
liteal lymph nodes of C5aR+/+ or C5aR/ SKG mice 8 wk after man-
nan treatment. (C) Intracellular staining of IL-17 and IFN- in CD4+ 
T cells in the popliteal lymph nodes of C5aR+/+ or C5aR / SKG 
mice, as shown in B (numbers indicate percentages). One represen-
tative staining out of nine independent experiments is shown.  
(D and E) Percentages (D) and absolute numbers (E) of IL-17+ cells in 
CD4+ T cells in each group (n = 9), as shown in C. (F) Joint scores of 
C5aR+/+ or C5aR/ SKG mice 8 wk after treatment by laminarin  
(n = 7) or zymosan (n = 6). (G) C3 deposition assay with laminarin-, 
zymosan-, or mannan-coated wells incubated with 2% sera from 
MASP-intact or -null C57BL/6 sera. (H) C5a ELISA for the superna-
tant of the C3 deposition assay with BALB/c sera, as shown in G. 
Error bars are means ± SD. (I) C5aR+/+ and C5aR/ SKG mice were 
i.p. injected with TNP-BSA alone or IgG3 anti-TNP/TNP-BSA IC.  
The percentage of IL-17+ cells in the peritoneal CD4+ T cells was 
assessed on day 7 (n = 4). Horizontal bars are the means.1138 Complement drives Th17 cell differentiation | Hashimoto et al.
(Fig. S2), even in the presence of TGF-. Without 
TGF-, CD4+ T cells cultured with DCs differentiated 
primarily into IFN-+ cells. Addition of C5a slightly 
decreased the percentage of IFN-+ cells but did not 
evoke Th17 cell differentiation (Fig. 3 D).
To determine whether the induction of Th17 
cells by C5a in CD4+ T cell/macrophage co-culture 
depended on a direct effect of C5a on CD4+ T cells or 
macrophages, we performed criss-cross co-cultures with 
C5aR+/+ or C5aR/ CD4+ T cells and C5aR+/+ or 
C5aR/ macrophages (Fig. 3 E). Th17 cell differentia-
tion was inhibited when macrophages, but not CD4+ 
T cells, lacked C5aR, suggesting that cytokines pro-
duced by C5a-stimulated macrophages were respon-
sible for inducing Th17 cell differentiation. Indeed, 
C5a elicited a dose-dependent production of large 
amounts of IL-6 and, to a lesser degree, TNF and 
IL-1 from resident peritoneal macrophages (Fig. 3 F). 
Production of IL-23, which is essential for the survival 
and expansion of Th17 cells, was up-regulated at the mRNA 
level in C5a-treated macrophages, although the cytokine 
was below the detection limit (30 pg/ml) of ELISA (Fig. 3 F). 
C5a also up-regulated co-stimulatory molecules such as 
CD86 on C5aR+/+ macrophages but not on C5aR/ macro-
phages (Fig. 3 G; Strainic et al., 2008).
C5a drives Th17 cell differentiation in synergy  
with GM-CSF or TLR signaling
Next we asked whether the in vitro robust expansion of 
Th17 cells was mediated by C5a alone or by a synergy of C5a 
and LPS, because the recombinant C5a we used contained a 
trace amount of contaminated LPS, which could synergistically 
naive  CD4+  T  cells  co-cultured  with  resident  peritoneal 
macrophages (as CD11bhighF4/80+Gr-1 cells) in the pres-
ence  of  TGF-  spontaneously  differentiated  into  IL-17+ 
cells, and addition of recombinant C5a dramatically increased 
IL-17+ cells but not IFN-+ cells; anti–IL-6R completely in-
hibited the increase (Fig. 3 C). This Th17-promoting effect 
of C5a was greater on naive (CD44lowCD45Rbhigh) CD4+ 
T cells than memory (CD44highCD45Rblow) CD4+ T cells 
(unpublished data). The in vitro C5a-mediated expansion of 
Th17 cells also occurred with thioglycollate-elicited perito-
neal macrophages, but to a much lesser extent compared with 
resident peritoneal macrophages (Fig. S2). Importantly, these 
effects  with  macrophages  were  not  observed  with  splenic 
DCs (Fig. 3 D) or with DCs from mannan-treated SKG mice 
Figure 3.  C5a acts on tissue-resident macrophages to 
facilitate Th17 cell differentiation. (A) F4/80+ cells in the 
peritoneal cavity, and Gr-1high, CD11chigh, and CD4+ cells in the 
spleen of nontreated SKG mice were stained for C5aR (continu-
ous line) or isotype control (shading). (B) Cells infiltrating in the 
arthritic joint of mannan-treated SKG mice were stained for 
C5aR, CD11b, Gr-1, and F4/80. C5aR+ CD11b+ cells are shown for 
the expression of Gr-1 and F4/80. (C) BALB/c CD4+ T cells were 
stimulated with anti-CD3 and cultured with resident peritoneal 
macrophages in the presence or absence of TGF-, recombinant  
C5a, or anti–IL-6R, and stained for intracellular cytokines on day 3.  
(D) Intracellular cytokine staining of BALB/c CD4+ T cells cultured 
with splenic DCs in the presence or absence of TGF- and C5a. 
(E) Intracellular cytokine staining of CD4+ T cells after criss-cross 
co-culture with C5aR+/+ or C5aR/ CD4+ T cells and C5aR+/+ or 
C5aR/ macrophages in the presence of TGF-. (F) ELISA  
assessment (triplicates) for IL-6, TNF, and IL-1 produced by 
macrophages, or quantitative RT-PCR for their IL-23 mRNA  
expression, when macrophages were stimulated overnight by 
C5a at the indicated doses. Error bars are means ± SD. (G) CD86 
expression on C5aR+/+ or C5aR/ macrophages cultured with or 
without C5a for 4 h. Shading indicates isotype control. Results in 
A–G represent three independent experiments. Numbers in B–E 
indicate percentages.JEM VOL. 207, June 7, 2010  1139
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lated BALB/c naive CD4+ T cells contained only a small 
number of GM-CSF–secreting cells (Fig. 4 D), their co-
culture with resident macrophages under anti-CD3 stim-
ulation markedly increased the proportion of GM-CSF+ 
T cells, and C5a further increased the proportion (Fig. 4 E). 
GM-CSF+ T cells were distinct from Th17 cells, whose 
expansion in the presence of C5a and TGF- accom-
panied a slight decrease in GM-CSF+ T cells (Fig. 4 E). 
In vivo, splenic CD4+ T cells in SKG mice contained 
sizable proportions of Th17 cells and GM-CSF+ CD4+ 
T cells; one half of the latter also secreted IFN- (Fig. 4 D 
and not depicted).
Collectively, the results in Fig. 3 and Fig. 4 indicate 
that C5a acts on macrophages in the joint and other 
tissues to provoke their production of IL-1, IL-6, TNF, 
and  IL-23,  and  together  with  tissue  TGF-,  promotes   
the differentiation and expansion of self-reactive T cells into 
Th17 cells. C5a stimulates macrophages to produce IL-6 in at 
least two ways: via synergy with TLR signaling and via T cell–
macrophage interaction. In the latter, GM-CSF produced by 
activated T cells enhances IL-6 production by C5a-stimulated 
macrophages, indicating a novel pathway of promoting Th17 
cell differentiation and expansion.
Macrophages are required for in vivo Th17 expansion  
and induction of arthritis
To determine the role of macrophages in vivo, we treated SKG 
mice with clodronate liposome (CL), which specifically depletes 
monocytes and macrophages (Solomon et al., 2005). The treat-
ment indeed efficiently depleted C5aR+ monocytes/macro-
phages without affecting neutrophils or DCs in SKG mice 
(Fig. 5 A). CL administration before mannan injection markedly 
attenuated the development of arthritis (Fig. 5 B) and re-
duced the expansion of Th17 cells (Fig. 5 C).
C5aR signaling promotes spontaneous differentiation  
of CD4+ T cells to Th17 cells via homeostatic proliferation
Similar to innate immune stimulation by microbial products, 
aseptic stimulation of SKG self-reactive T cells (e.g., via homeo-
static proliferation in a lymphopenic environment) evokes 
act to drive Th17 cell differentiation (see Materials and methods; 
Fang et al., 2009). To dissect TLR-dependent and -independent 
effects, we used macrophages from TLR4/ or MyD88/ 
mice. Although a deficiency of TLR4/ or MyD88/ in 
macrophages substantially reduced the C5a-mediated expan-
sion of Th17 cells, a significant proportion of Th17 cells still 
developed (Fig. 4 A). Further, C5a derived from LPS-free hu-
man plasma expanded Th17 cells (unpublished data; Köhl, 1997). 
Notably, when TLR4/ or MyD88/ macrophages alone 
were stimulated by C5a, IL-6 production was nearly abolished 
(Fig. 4 B). However, in co-culture with anti-CD3–stimulated 
IL-6/ CD4+ T cells, C5a significantly enhanced IL-6 pro-
duction by TLR4/ or MyD88/ macrophages, although 
much less potently compared with wild types (Fig. 4 B).
To analyze how T cells contributed to the C5a-induced 
IL-6 production by macrophages, we assessed the effect of co-
stimulatory molecules and T cell–derived cytokines that could 
alter macrophage function (Grabstein et al., 1986). IL-6 pro-
duction was partially inhibited by blockade of CD40L (Fig. S3; 
Hirota et al., 2007). When TLR4/ or MyD88/ macro-
phages alone were stimulated with C5a in the presence or 
absence of various cytokines (e.g., IL-17, IL-21, IFN-, and 
GM-CSF), only GM-CSF significantly enhanced IL-6 pro-
duction even at a low concentration (e.g., 1 ng/ml; Fig. 4 C 
and Fig. S3; Sonderegger et al., 2008). Although freshly iso-
Figure 4.  C5a drives Th17 cell differentiation in synergy with 
TLR or GM-CSF. (A) C57BL/6 CD4+ T cells were cultured with 
TLR4/, MyD88/, or wild-type C57BL/6 macrophages in the pres-
ence of TGF- with or without C5a. (B) Macrophages alone from 
these mice or co-cultured with anti-CD3–stimulated CD4+ T cells 
from IL-6/ mice were stimulated with C5a overnight. IL-6 in the 
supernatant was determined by ELISA. (C) MyD88/ macrophages 
were stimulated by C5a overnight in the presence or absence of 
cytokines at the indicated doses. IL-6 in the supernatant was deter-
mined by ELISA (triplicates). Error bars are means ± SD. (D) Freshly 
isolated BABL/c or SKG splenic CD4+ T cells were stained for intra-
cellular IL-17 and GM-CSF. (E) BALB/c CD4+ T cells were cultured 
with macrophages in the presence or absence of C5a and/or TGF-, 
stimulated with anti-CD3, and stained for intracellular cytokines on 
day 3. Results in A–E represent three independent experiments. 
Numbers in A, D, and E indicate percentages.1140 Complement drives Th17 cell differentiation | Hashimoto et al.
C5aR-deficient recipients (Fig. 6 E). Collectively, these re-
sults indicate that interactions between self-reactive T cells and 
APCs can preferentially drive the differentiation of the former 
into Th17 effector cells via complement activation and the 
resulting C5a action on APCs.
Thus,  extrinsic  and  intrinsic  complement  activation   
promotes Th17 cell differentiation and expansion, evoking   
autoimmune arthritis in SKG mice (Fig. 6 F). It was noted, 
however, that C5aR deficiency significantly suppressed but 
did not completely inhibit arthritis development triggered by 
laminarin, zymosan, or mannan (Fig. 2). This incomplete in-
hibition could be attributed to the fact that these microbial 
products not only activate complement but also directly stim-
ulate macrophages and DCs via cell surface–expressed pattern 
recognition receptors such as TLR and C-type lectin receptors 
(e.g., Dectin-1, mannose receptor, and DC-SIGN; Yoshitomi 
et al., 2005; Robinson et al., 2006; Sheng et al., 2006). Indeed, 
in our co-culture experiments with macrophages, zymosan, 
laminarin, or mannan at a high dose (1 mg/ml) expanded 
Th17 cells, presumably via IL-6 production in an MyD88-
dependent and -independent manner (Fig. S4). In addition, we 
observed a synergy between the signals from C5aR and MyD88 
for cytokine production by macrophages (Fig. 4 A; Fang et al., 
2009). Yet, it is of note that the prototypic TLR agonist LPS 
or CpG alone failed to elicit arthritis in SKG mice, in contrast 
to successful arthritis induction by mannan, a prototypic com-
plement activator (Yoshitomi et al., 2005). This indicates that 
complement activation and C5a production can be a major 
pathway for driving Th17-dependent autoimmune arthritis in 
SKG mice.
Because C5a, IL-17, and GM-CSF are commonly capa-
ble of enhancing granulopoiesis and neutrophil recruitment 
(Höpken et al., 1996; Korn et al., 2009), together they would 
cause robust neutrophil accumulation (Fig. 3 B) and form 
a  positive feedback loop of Th17-mediated inflammation 
(Fig. 6 H; Sonderegger et al., 2008). In addition, the carti-
lage surface lacks several complement inhibitors, which might 
render the joint highly susceptible to complement activation 
(Matsumoto et al., 2002). It is thus likely that transient syno-
vial inflammation may frequently occur when an individual 
is  exposed  to  complement-activating  microbial  products, 
ICs, autoantibodies, or physical trauma. Such synovial in-
flammation per se may not be sufficient to trigger chronic 
arthritis in normal individuals. Yet, if an individual harbors 
potentially arthritogenic CD4+ T cells (e.g., because of genetic 
predisposition), such complement-induced synovial inflam-
mation may promote the differentiation/expansion of arthri-
togenic Th17 cells and instigate chronic arthritis. It is worth 
noting in this regard that genetic susceptibility to RA is in 
part determined by the polymorphism of the genes encoding 
C5 (TRAF1-C5), PTPN22 (which affects TCR proximal 
signaling, as observed with the SKG ZAP-70 mutation), or 
STAT4, which might alter Th17 cell function (Vang et al., 
2005; Plenge et al., 2007; Remmers et al., 2007). These   
genetic polymorphisms could promote the production of 
arthritogenic T cells and their Th17 cell differentiation via 
spontaneous differentiation of Th17 cells and triggers auto-
immune arthritis (Hirota et al., 2007). Because T cell–APC 
interaction induces local complement activation (Liu et al., 
2008; Strainic et al., 2008), we asked whether such intrinsic 
complement activation would contribute to Th17 cell differen-
tiation and arthritis induction. In RAG2/ mice that devel-
oped arthritis after transfer of SKG CD4+ T cells, the joint tissue 
actively transcribed C3 and IL-6 mRNA, indicating com-
plement activation and IL-6 production in the affected joint 
(Fig. 6 A). When CD4+ T cells from C5aR+/+ or C5aR/ 
SKG mice were transferred to C5aR+/+ or C5aR/ RAG2/ 
mice, both CD4+ T cell populations induced arthritis at 
equivalent incidences and severities in C5aR+/+ RAG2/ 
mice but were significantly lower in C5aR/RAG2/ mice 
(Fig. 6 B). Thus, C5aR expression by the recipient cells, not 
donor CD4+ T cells, was required for disease induction. In 
accordance with the joint scores, the generation of Th17 cells 
from transferred CD4+ T cells was significantly suppressed in 
C5aR/ recipients (Fig. 6, C and D). The generation of 
IFN-–secreting cells was not significantly affected, although 
there was a tendency toward a higher proportion of IFN-+ 
cells in C5aR/ recipients. Inhibition of Th17 cell differen-
tiation by C5aR deficiency was not restricted to SKG CD4+ 
T cells, as Th17 cell differentiation of BALB/c CD4+ T cells 
during homeostatic proliferation was also suppressed in 
Figure 5.  Macrophages are required for in vivo Th17 expansion 
and induction of arthritis. (A) Specific depletion of macrophages in SKG 
mice 3 d after i.v. injection of 200 µl CL. One representative out of three 
independent experiments is shown (numbers indicate percentages).  
(B) Joint scores of SKG mice i.v. injected with 200 µl PBS or CL 1 d before 
mannan treatment. *, P < 0.05. Error bars are means ± SD. (C) Percentage 
of IL-17+ CD4+ T cells in the popliteal lymph nodes of SKG mice 2 wk after 
mannan treatment. Mice were pretreated by an i.v. injection of PBS or CL 
(n = 6). Horizontal bars are the means.JEM VOL. 207, June 7, 2010  1141
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Antibodies. For flow-cytometric analysis, anti-CD4 (RM4-5), anti–IL-17 
(TC11-18H10.1),  anti–IFN-  (XMG1.2),  anti-CD11b  (M1/70),  anti-
CD11c (HL3), anti–Gr-1 (RB6-8C5), and isotype IgG were purchased from 
eBioscience;  anti–GM-CSF  (MP1-22E9)  was  purchased  from  BD;  anti-
C5aR (20/70) was purchased from Cedarlane; and anti-F4/80 (A3-1) was 
purchased from AbD Serotec.
Cell  culture.  Resident  peritoneal  macrophages  were  sorted  by  MoFlo 
(Dako) for FSChigh, SSChigh, CD11bhigh cells from lavage of the BALB/c   
peritoneal cavity with 10 ml PBS containing 2% FCS and 2 mM EDTA. 
Thioglycollate-elicited peritoneal macrophages were prepared as previously 
described (Zhang et al., 2007). Splenic DCs were sorted for CD11chigh cells in 
BALB/c spleens treated with Librase Blenzyme II (Roche). 2.5 × 104 CD4+ 
T cells were cultured with 1.25 × 104 macrophages or DCs in RPMI 1640 
medium (Sigma-Aldrich) containing 10% FCS, and were stimulated with 
0.5 µg/ml anti-CD3 (2C11) with or without 500 ng/ml C5a (R&D Sys-
tems), 10 ng/ml TGF- (PeproTech), or 10 µg/ml anti–IL-6R (MR16-1).
C3 deposition assay. Maxi-Plates (Thermo Fisher Scientific) were coated 
with 100 µg/ml laminarin, zymosan, or mannan. After blocking, wells were 
incubated with 2% mouse sera diluted with TBS/Tween/Ca (0.1% BSA, 
0.05% Tween 20, 5 mM CaCl2) at 37°C for 30 min. C3c deposited on the well 
surfaces was detected by anti–human C3c (Dako) followed by horseradish per-
oxidase–conjugated secondary antibody (Dako), and assessed by ELISA. Super-
natants from the C3c deposition assay were assessed for the concentration of 
C5a by ELISA and expressed as the concentrations in the original sera.
Quantitative RT-PCR. Total RNA of peritoneal macrophages was ex-
tracted 24 h after incubation with 500 ng/ml C5a using the RNeasy column 
complement activation. Although C5aR signaling plays a com-
plex role depending on the cell types (e.g., macrophages or 
DCs) and additional receptors (e.g., TLRs; Guo and Ward, 
2005; Weaver et al., 2010), this report provides evidence that 
complement activation and C5a production is critically in-
volved in the initiation of certain autoimmune disease, and pre-
sumably microbial immunity, by driving Th17 development.
MATERIALS AND METHODS
Mice. C5aR/, IL-17/, IL-6/, RAG2/, TLR4/, and MyD88/ 
mice (TLR4- or MyD88-deficient mice were provided by S. Akira, Osaka 
University, Osaka, Japan) were described previously (Hawlisch et al., 2005; 
Yoshitomi et al., 2005; Hirota et al., 2007). MASP-null mice were generated 
by crossing MASP1/3/ and MASP2/sMAP/ mice (Iwaki et al., 2006; 
Takahashi et al., 2008). All mice were maintained in a SPF condition in our 
animal facility in accordance with the guidelines for animal care approved by 
the Institute for Frontier Medical Sciences, Kyoto University.
Reagents. Recombinant mouse C5a was purchased from R&D Systems. 
Mannan from Saccharomyces cerevisiae was purchased from Sigma-Aldrich and 
was dissolved in 200 µl PBS before i.p. injection. The endotoxin level in the 
reagents used in the current study was 0.44 EU/ml for 1 µg/ml C5a and 6.14 
EU/ml for 1 mg/ml mannan, 4.01 EU/ml for 1 mg/ml laminarin, and <0.001 
EU/ml for plasma-derived C5a, as determined by the LAL test (Wako Chem-
icals USA, Inc.). Plasma-derived C5a was purified from human EGTA-plasma 
as previously described (Köhl, 1997). CL was a gift from Roche, and the lipo-
somal preparation was prepared as previously described (Solomon et al., 2005). 
IgG3-IC was prepared as previously described (Díaz de Ståhl et al., 2003).
Figure 6.  C5a promotes spontaneous differentiation of CD4+ T cells to Th17 cells via homeostatic proliferation. (A) Quantitative RT-PCR for 
C3 and IL-6 mRNA in the joints of RAG2/ mice 12 wk after transfer of SKG CD4+ T cells (n = 6). (B) 106 C5aR+/+ or C5aR/ SKG CD4+ T cells were trans-
ferred to C5aR+/+ or C5aR/ RAG2/ mice. Joint scores were assessed every week in two independent experiments. Error bars are means ± SD. (C) 2 × 
106 C5aR+/+ or C5aR/ SKG CD4+ T cells were transferred to C5aR+/+ or C5aR/ RAG2/ mice. Intracellular cytokines in recipient splenic CD4+ T cells 
were stained on day 7 (numbers indicate percentages). One representative out of four independent experiments is shown. (D and E) Percentages of IL-17+ 
or IFN-+ cells among CD4+ T cells in C5aR+/+ or C5aR/ RAG2/ mice (n = 4 each) after transfer of SKG (D) or BALB/c CD4+ T cells (E). (F) A model for 
the role of complement activation in Th17-mediated autoimmune arthritis. Horizontal bars in A, D, and E are the means.1142 Complement drives Th17 cell differentiation | Hashimoto et al.
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(QIAGEN). Total RNA of joint tissues was extracted by Isogen (Wako 
Chemicals USA, Inc.) according to the manufacturer’s instructions. cDNA 
was transcribed by reverse transcription (SuperScript III; Invitrogen), and the 
genes  were  quantified  by  the  SYBR  Green  I  system  using  LightCycler 
(Roche). Gene expression was normalized to expression of the HPRT gene. 
IL-23, C3, and IL-6 primer sequences are as follows: IL-23 forward, 5-TCC-
CTACTAGGACTCAGCCAAC-3;  IL-23  reverse,  5-TGGGCATC-
TGTTGGGTCT-3; C3 forward, 5-TTCGTCCTCATCGCACTG-3; 
C3 reverse, 5-TGTAACTGGCTTCAATATACTCC-3; IL-6 forward, 
5-CCACTTCACAAGTCGGAGGCTTA-3; and IL-6 reverse, 5-GCAA-
GTGCATCATCGTTGTTCATAC-3.
ELISA. ELISA for C3a, C5a, and cytokines was performed according to the 
manufacturer’s instructions (BD). For measuring in vivo complement activa-
tion, futhan (FUT-175; BD) was added to the plasma preparation to prevent 
ex vivo complement activation.
Clinical assessment of joint scores, intracellular cytokine staining, 
and preparation of synovial cells. These were performed as described 
previously (Hirota et al., 2007).
Statistical analysis. The in vivo joint scores were analyzed by the Mann-
Whitney U test. Unless otherwise mentioned, the Student’s t test was used 
for statistical analysis. P < 0.05 was considered significant.
Online supplemental material. Fig. S1 shows C3a/C5a production and early 
Th17 cell expansion after mannan treatment. Fig. S2 depicts the dependency 
of C5a/TGF-–induced Th17 cell development on the type of APCs. Fig. S3 
shows the effect of co-stimulation and T cell–derived cytokines on IL-6 pro-
duction by C5a-stimulated macrophages. Fig. S4 depicts TLR-dependent IL-6 
production by laminarin, zymosan, or mannan. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20092301/DC1.
The authors thank R. Ishii and M. Kakino for technical assistance, T. Matsushita for 
histology, Z. Fehervari and P. Gannon for critically reading the manuscript,  
K. Tsuchiya for advice on the LAL test, S. Akira for providing TLR4- or MyD88-deficient 
mice, and the members of our laboratory for valuable discussion.
This work was supported by grants-in-aid from the Ministry of Education, 
Culture, Sports, Science, and Technology.
The authors have no conflicting financial interests.
Submitted: 26 October 2009
Accepted: 8 April 2010
REFERENCES
Díaz de Ståhl, T., J. Dahlstrom, M.C. Carroll, and B. Heyman. 2003. A 
role for complement in feedback enhancement of antibody responses by 
IgG3. J. Exp. Med. 197:1183–1190. doi:10.1084/jem.20022232
Fang,  C.,  X.  Zhang,  T.  Miwa,  and  W.C.  Song.  2009.  Complement   
promotes the development of inflammatory T-helper 17 cells through   
synergistic  interaction  with  Toll-like  receptor  signaling  and   
interleukin-6 production. Blood. 114:1005–1015. doi:10.1182/blood- 
2009-01-198283
Fujita, T. 2002. Evolution of the lectin-complement pathway and its role in 
innate immunity. Nat. Rev. Immunol. 2:346–353. doi:10.1038/nri800
Garlatti, V., N. Belloy, L. Martin, M. Lacroix, M. Matsushita, Y. Endo, 
T.  Fujita,  J.C.  Fontecilla-Camps,  G.J.  Arlaud,  N.M.  Thielens,  and 
C. Gaboriaud. 2007. Structural insights into the innate immune rec-
ognition  specificities  of  L-  and  H-ficolins.  EMBO  J.  26:623–633. 
doi:10.1038/sj.emboj.7601500
Grabstein, K.H., D.L. Urdal, R.J. Tushinski, D.Y. Mochizuki, V.L. Price, 
M.A. Cantrell, S. Gillis, and P.J. Conlon. 1986. Induction of macro-
phage tumoricidal activity by granulocyte-macrophage colony-stimulating 
factor. Science. 232:506–508. doi:10.1126/science.3083507
Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annu. 
Rev.  Immunol.  23:821–852.  doi:10.1146/annurev.immunol.23.021704 
.115835JEM VOL. 207, June 7, 2010  1143
Brief Definitive Report
Strainic,  M.G.,  J.  Liu,  D.  Huang,  F.  An,  P.N.  Lalli,  N.  Muqim,  V.S. 
Shapiro, G.R. Dubyak, P.S. Heeger, and M.E. Medof. 2008. Locally 
produced complement fragments C5a and C3a provide both costimula-
tory and survival signals to naive CD4+ T cells. Immunity. 28:425–435. 
doi:10.1016/j.immuni.2008.02.001
Sylvestre, D., R. Clynes, M. Ma, H. Warren, M.C. Carroll, and J.V. Ravetch. 
1996. Immunoglobulin G–mediated inflammatory responses develop 
normally in complement-deficient mice. J. Exp. Med. 184:2385–2392. 
doi:10.1084/jem.184.6.2385
Takahashi, M., D. Iwaki, K. Kanno, Y. Ishida, J. Xiong, M. Matsushita, Y. 
Endo, S. Miura, N. Ishii, K. Sugamura, and T. Fujita. 2008. Mannose-
binding lectin (MBL)-associated serine protease (MASP)-1 contributes to 
activation of the lectin complement pathway. J. Immunol. 180:6132–6138.
Vang, T., M. Congia, M.D. Macis, L. Musumeci, V. Orrú, P. Zavattari, 
K. Nika, L. Tautz, K. Taskén, F. Cucca, et al. 2005. Autoimmune-
associated lymphoid tyrosine phosphatase is a gain-of-function variant. 
Nat. Genet. 37:1317–1319. doi:10.1038/ng1673
Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 
2006. TGFbeta in the context of an inflammatory cytokine milieu sup-
ports de novo differentiation of IL-17-producing T cells.  Immunity. 
24:179–189. doi:10.1016/j.immuni.2006.01.001
Weaver,  D.J.,  Jr.,  E.S.  Reis,  M.K.  Pandey,  G.  Köhl,  N.  Harris,   
C.  Gerard,  and  J.  Köhl.  2010.  C5a  receptor-deficient  dendritic 
cells promote induction of Treg and Th17 cells. Eur. J. Immunol. 
40:710–721.
Yoshitomi, H., N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. 
Sakihama, K. Hirota, S. Tanaka, T. Nomura, I. Miki, et al. 2005. A 
role for fungal -glucans and their receptor Dectin-1 in the induction 
of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 
201:949–960. doi:10.1084/jem.20041758
Zhang, X., Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J.D. Lambris, R.A. 
Wetsel, T. Miwa, and W.C. Song. 2007. Regulation of Toll-like   
receptor-mediated inflammatory response by complement in vivo. 
Blood. 110:228–236. doi:10.1182/blood-2006-12-063636